Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRPC (metastatic Castration-resistant Prostate Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06321679
What this trial is testing

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
European Institute of Oncology 40
Testing effectiveness (Phase 2)Looking for participantsNCT07206056
What this trial is testing

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

Who this might be right for
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals 188
Large-scale testing (Phase 3)Active Not RecruitingNCT02257736
What this trial is testing

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Aragon Pharmaceuticals, Inc. 982
Testing effectiveness (Phase 2)Looking for participantsNCT07451795
What this trial is testing

SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC

Who this might be right for
Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)
Fudan University 66
Early research (Phase 1)Not Yet RecruitingNCT07682649
What this trial is testing

Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
University of Michigan Rogel Cancer Center 20
Not applicableStudy completedNCT05701007
What this trial is testing

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 1,083
Very early researchStudy completedNCT05725070
What this trial is testing

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
ARTBIO Inc. 3
Very early researchLooking for participantsNCT07156045
What this trial is testing

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Castration-resistant Prostate Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10
Testing effectiveness (Phase 2)Looking for participantsNCT06134232
What this trial is testing

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Dendreon 400
Early research (Phase 1)Looking for participantsNCT06531499
What this trial is testing

Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Novartis Pharmaceuticals 106
Testing effectiveness (Phase 2)Study completedNCT01289067
What this trial is testing

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

Who this might be right for
Prostate Cancer
William K. Oh 13
Early research (Phase 1)Looking for participantsNCT05743621
What this trial is testing

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Weill Medical College of Cornell University 30
Early research (Phase 1)Active Not RecruitingNCT04506567
What this trial is testing

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 60
Early research (Phase 1)Study completedNCT01385228
What this trial is testing

Pazopanib, Docetaxel, Prednisone Prostate

Who this might be right for
Prostate Cancer
Daniel George, MD 36
Very early researchNot Yet RecruitingNCT06546527
What this trial is testing

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Who this might be right for
Prostate Cancer
Peking University First Hospital 12
Early research (Phase 1)Temporarily pausedNCT05425862
What this trial is testing

Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia 48
Very early researchNot Yet RecruitingNCT07609225
What this trial is testing

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Wisconsin, Madison 15
Not applicableUnknownNCT04833517
What this trial is testing

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Who this might be right for
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Universität des Saarlandes 500
Testing effectiveness (Phase 2)Looking for participantsNCT06236139
What this trial is testing

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 48
Not applicableStudy completedNCT03563014
What this trial is testing

A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 164
Next Page